[1] O′LEARY N,JAIRAJ C,MOLLOY E J,et al.Antenatal depression and the impact on infant cognitive,language and motor development at six and twelve months postpartum[J].Early Hum Dev,2019,134: 41-46.
[2] 四川美康医药软件研究开发公司.药物临床信息参考2008[M].重庆:重庆出版社,2008:附录1751.
[3] 冯缨缨,顾祖维.女工孕期接触药物对胎儿危害的分级——妊娠期哺乳期用药指南[J].工业卫生与职业病,2002,28(1):52-58.
[4] 陈绪柳.妊娠期妇女用药研究进展[J].临床合理用药杂志,2012,5(12):151-152.
[5] 蒋式时,邵守进,陶如风.妊娠期哺乳期用药[M].第2版.北京:人民卫生出版社,2010:11.
[6] GENTILE S.Tricyclic antidepressants in pregnancy and puerperium[J].Expert Opin Drug Saf,2014,13(2):207-225.
[7] KJAERSGAARD M I,PARNER E T,VESTERGAARD M,et al.Prenatal antidepressant exposure and risk of spontaneous abortion - a population-based study[J].PLoS One,2013,8(8):e72095.
[8] FURU K,KIELER H,HAGLUND B,et al.Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design[J].BMJ,2015,350:1798.
[9] KIEVIET N,DOLMAN K M,HONIG A.The use of psychotropic medication during pregnancy: how about the newborn[J]. Neuropsychiatr Dis Treat,2013,9: 1257-1266.
[10] Administration USFAD.FDA drug safety communication:Selective serotonin reuptake inhibitor (SSRI) antidepressant use during pregnancy and reports of a rare heart and lung condition in newborn babies[EB/OL].[2018-11-10].http://www.fda.gov/Drugs/DrugSafety/ucm283375.htm.
[11] PEDERSEN L H.Prenatal Antidepressant Exposure and Childhood Autism Spectrum Disorders: Cause for Concern[J].Paediatr Drugs,2015,17(6):443-448.
[12] National Institute for Health and Care Excellence.An tenatal and postnatal mental health: clinical management and service guidance( CG192)[EB/OL].(20141217)[2018-03-13].https://www.nice.org.uk/guidance/cg192/chapter/1-Recommendations. |
